NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Renal Disease



Recent studies by M. Hursitoglu and co-authors add new data to renal disease findings



March 3rd, 2009

According to recent research published in the journal Transplant Infectious Disease, "M. Hursitoglu, M.A. Cikrikcioglu, T. Tukek, I. Beycan, N. Ahmedova, S. Karacuha, M. Sansal, O. Ozkan, V. Celik. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON((R))-TB Gold In-Tube test in end-stage renal disease patients.Transpl Infect Dis 2009: 11: 28-32."

"All rights reserved Screening for latent tuberculosis infection before solid organ transplantation is mandatory, but this is not so easy in uremic patients on hemodialysis (HD) treatment. The newly developed interferon-gamma (IFN-gamma)-based QuantiFERON((R))-TB Gold...


Source: TB & Outbreaks Week (2009-03-03)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login